Selective dopamine receptor stimulation differentially affects [3H]arachidonic acid incorporation, a surrogate marker for phospholipase A2-mediated neurotransmitter signal transduction, in a rodent model of Parkinson's disease

Journal of Pharmacology and Experimental Therapeutics

Volumn 296, Issue 3, 2001, Pages 1074-1084

  Hayakawa, Takanori ^a,b   Chang, Michael C J ^a   Rapoport, Stanley I ^a   Appel, Nathan M ^a,c,d  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^d NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; ARACHIDONIC ACID; BUTACLAMOL; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR STIMULATING AGENT; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; QUINPIROLE; TRACER; TRITIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BASAL GANGLION; BRAIN CORTEX; BRAIN REGION; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DRUG EFFECT; HISTOPATHOLOGY; MALE; NEUROTRANSMISSION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SUBSTANTIA NIGRA;

2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE; ANIMALS; ARACHIDONIC ACID; BIOLOGICAL MARKERS; DISEASE MODELS, ANIMAL; DOPAMINE AGONISTS; MALE; NEUROTRANSMITTER AGENTS; PARKINSON DISEASE; PHOSPHOLIPASES A; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; SIGNAL TRANSDUCTION; TRITIUM;

EID: 0035123595     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. 1 receptor efficacy
2. Sequelae of parenteral domoic acid administration in rats: Comparison of effects on different metabolic markers in brain
3. Localization of dopaminergic markers in the human subthalamic nucleus
4. Reversal of experimental parkinsonism by lesions of the subthalamic nucleus
5. Dopamine-containing systems in the CNS
6. 2 subtypes of dopamine receptors in rat brain
7. Depletion of brain noradrenaline and dopamine by 6-hydroxydopamine
8. A positron emission tomographic study of subthalamic nucleus stimulation in Parkinson disease: Enhanced movement-related activity of motor-association cortex and decreased motor cortex resting activity
9. 11C]arachidonate in normocapnic and hypercapnic monkeys, measured with positron emission tomography
10. 2 receptors in the rat brain: Autoradiographic visualization using a high-affinity selective agonist ligand
11. Potential mechanisms involved in the negative coupling between serotonin 5-HT1A receptors and carbachol-stimulated phosphoinositide turnover in the rat hippocampus
12. D-1 dopamine receptors in the rat brain: A quantitative autoradiographic analysis
13. Arecoline-stimulated brain incorporation of intravenously administered fatty acids in unanesthetized rats
14. 14C]arachidonate to examine regional brain lipid metabolism in unanesthetized rats
15. 2 dopamine receptors
16. Verteilung von noradrenalin und dopamin (3-hydroxytryamin) im gehirn des menschen und ihr verhalten bei erkrankungen des extrapyramidalen systems
17. Serotonin stimulates phospholipase A2 and the release of arachidonic acid in hippocampal neurons by a type 2 serotonin receptor that is independent of inositolphospholipid hydrolysis
18. A simple method for the isolation and purification of total lipides from animal tissues
19. Incorporation of arachidonic and docosahexaenoic acids into phospholipids of rat brain membranes
20. 3 receptors in rat brain
21. Dopamine differentially regulates dynorphin, substance P, and enkephalin expression in striatal neurons: In situ hybridization histochemical analysis
22. Animal models of Parkinson's disease: An empirical comparison with the phenomenology of the disease in man
23. Neurosurgical horizons in Parkinson's disease
24. 2 inhibitor, inhibits arachidonate incorporation and turnover in brain phospholipids of the awake rat
25. 3H]arachidonic acid incorporation into rat brain after unilateral 6-hydroxydopamine lesions in the substantia nigra
26. Fatty acid incorporation depicts brain activity in a rat model of Parkinson's disease
27. 3H]arachidonic acid from blood into brain synaptosomal fractions before and after cholinergic stimulation
28. 2 dopamine receptors mediate the potentiation of arachidonic acid release in Chinese hamster ovary cells
29. Surgical treatment of Parkinson's disease
30. 2-like dopamine receptors in rat brain
31. 3 dopamine receptors in rat brain and pituitary gland: A quantitative autoradiographic study
32. Effect of butaclamol on dopamine-sensitive adenylate cyclase in rat striatum
33. 14C]arachidonate in awake rats, with or without cholinergic stimulation, following unilateral lesioning of nucleus basalis magnocellularis
34. 1, modify brain glucose brain metabolism
35. 2 receptor synergism
36. Selective acceleration of arachidonic acid reincorporation into brain membrane phospholipids following transient ischemia in awake gerbils
37. A quantitative method for measuring regional in vivo fatty-acid incorporation into and turnover within brain phospholipids: Review and critical analysis
38. Effects of substantia nigra lesions on forebrain 2-deoxyglucose retention in the rat
39. 2-dopamine receptors on arachidonic acid release and cyclic AMP production in striatal neurons
40. Unilateral 6-hydroxydopamine lesions of meso-striatal dopamine neurons and their physiological sequelae
41. Brain dopamine receptors
42. 2 receptors
43. The central effects of a novel dopamine agonist
44. Relation between physiological function and energy metabolism in the central nervous system
45. 14C]deoxyglucose method for the measurement of local cerebral glucose utilization: Theory, procedure, and normal values in the conscious and anesthetized albino rat
46. High agonist-independent activity is a distinguishing feature of the dopamine D1B receptor subtype
47. 14C]-2-deoxyglucose autoradiography
48. The effects of L-DOPA on regional cerebral glucose utilization in rats with unilateral lesions of the substantia nigra
49. 2 dopamine agonists differentially alter basal ganglia glucose utilization in rats with unilateral 6-hydroxydopamine substantia nigra lesions
50. Substantia nigra pars reticulata units in 6-hydroxydopamine-lesioned rats: Responses to striatal D2 dopamine receptor stimulation and subthalamic lesions
51. Postsynaptic supersensitivity after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system
52. 2
53. In vivo cerebral incorporation of radiolabeled fatty acids after acute unilateral orbital enucleation in adult hooded Long-Evans rats
54. In vivo imaging of brain incorporation of fatty acids and 2-deoxy-D-glucose demonstrates functional and structural neuroplastic effects of chronic unilateral orbital visual deprivation in rats
55. Comparison of the distribution of D-1 and D-2 dopamine receptors in the rat brain
56. Metabolic effects of unilateral lesion of the substantia nigra
57. Effects of dopaminergic stimulation on functional brain metabolism in rats with unilateral substantia nigra lesions